A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Jenna Brashear
| Share Statistics | ALLR | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $14.2 | $208.8 | 9% |
|
| Shares Out (Mil) | 15.9 | 53.9 | 27% |
|
| Institutional Ownership | 92.4% | 93.1% | 61% |
|
| Float (Mil) | 15.8 | 41.4 | 25% |
|
| Beta | 0.51 | 0.95 | 29% |
|
| Avg Daily Volume (000s) | 146 | 614 | 41% |
|
| Price Change (52-week) |
(40.3%) | 45.3% | 25% |
|
| Growth | ALLR | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 12.8% | na |
|
| Net Income (5yr) | (11.2%) | (10.2%) | 28% |
|
| EPS (5yr) | na | 15.7% | na |
|
| Dividends (5yr) | na | 0.0% | 0% |
|
| Cash Flow (5yr) | na | (15.7%) | na |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 1 | 1 | 1 | |
| Current EPS | ($0.210) | ($0.800) | ($0.860) | |
| Month Ago EPS | ($0.250) | ($0.920) | ($0.970) | |
| # Rev Up | 0 | 0 | 0 | |
| # Rev Down | 1 | 1 | 1 | |
| Three Months Ago EPS | ($0.250) | ($0.920) | ($0.970) | |
| Year/Year Chg | (1.9%) | 2.4% | na | |
| Financials | ALLR | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $0 | $37 | 1% |
|
| Net Income (TTM) (Mil) | ($12) | ($44) | 28% |
|
| EPS (TTM) | ($0.787) | ($1.600) | 24% |
|
| Operating Cash Flow (TTM) (Mil) | ($14) | ($33) | 18% |
|
| Net Cash Flow (TTM) (Mil) | na | $2 | na |
|
| Long-Term Debt (Q1) (Mil) | $0 | $4 | 0% |
|
| Enterprise Value (Q1) (Mil) | $28 | $174 | 13% |
|
| Valuation | ALLR | Industry Median |
Percentile (All Stocks) |
|
| P/B | 4.07 | 2.09 | 76% |
|
| P/E | na | 19.5 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 1.0 | na |
|
| Ratios | ALLR | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 100.0% | 66.0% | 96% |
|
| Net Margin | na | (75.3%) | na |
|
| ROA | (46.3%) | (47.2%) | 12% |
|
| ROE | (157.1%) | (54.2%) | 6% |
|
| Liabilities to Assets | 89.0% | 29.1% | 84% |
|
| F-Score | 1 | 2 | 1% |
|
Allarity Therapeutics, Inc. did not pass any screens on 10/16/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors
